Metabolon is a proud sponsor of the Molecular Med Tri-Conference being held in San Francisco, CA from February 11-16, 2018. You'll find us at Booth #2003.

 

Also, please join us for a presentation to learn more about how Precision Metabolomics™ can enhance your R&D efforts.

Precision Metabolomics™ - Current State and Future Plans

 

Thursday, February 15, 2018

10:00 – 10:30am PST

Moscone Convention Center

 

Presented by Luke Miller, PhD

Vice President, Lab Operations, Metabolon

 

We will present an overview of Precision Metabolomics, an advanced approach to metabolomics that has the sensitivity and specificity to accurately measure metabolites at a level that makes an n of 1 study in an individual practicable. This approach uses extensively controlled processes to provide data with the smallest degree of variability in the measurement (<5%) to allow precise identification of the maximum possible number of biologically relevant metabolites in a sample. The goal is to comprehensively and reproducibly map metabolism and metabolic change induced by perturbation, such as disease or treatment, with sufficient precision to produce actionable information at the level of the individual.

 

At Metabolon, we have put this technology into practice, with processes that are tightly regulated through infrastructure controls, documented SOPs, labelled internal standards and proprietary informatics, and the use of a tier one approach to identification of metabolites in each sample. In this presentation, Dr. Miller will discuss the technology that that allows us to carry out n of 1 studies that enable precision medicine, demonstrate the importance of metabolomics alongside genomic studies, and discuss some of our future technology improvements to continue to expand our capabilities.

 

Location:

Moscone Convention Center

747 Howard Street

San Francisco, CA  94103